Examkin

Question

Difficulty: HardImmunologic and Inflammatory Processes

A detailed understanding of cytokine networks and immune cell interactions is essential for recognizing the pathogenesis of various inflammatory, autoimmune, and infectious conditions, as well as for utilizing targeted biologic therapies. Match each clinical presentation or pathologic process with the primary cytokine or immunologic mechanism that directly drives its development.

  • Maintenance of granulomas in chronic Mycobacterium tuberculosis infectionInterferon-gamma (IFN-γ\gamma) produced by Th1 cells leading to robust macrophage activation
  • Epidermal hyperplasia and neutrophil recruitment in psoriatic plaquesInterleukin-17 (IL-17) and Interleukin-23 (IL-23) driven inflammatory cascades
  • Eosinophil recruitment, activation, and survival in allergic asthmaInterleukin-5 (IL-5) secretion by Th2 cells
  • Widespread capillary leak and distributive shock in toxic shock syndromeSuperantigen-mediated cross-linking of MHC-II and T-cell receptors causing massive cytokine release
  • Isotype switching to IgE during helminthic infections and atopic dermatitisInterleukin-4 (IL-4) signaling stimulating B-cell class switching

Answer

The correct matching aligns specific immune mediators with their hallmark clinical manifestations: granulomas are maintained by IFN-gamma, psoriasis is driven by the IL-17/IL-23 axis, eosinophilia in asthma depends on IL-5, toxic shock syndrome is triggered by superantigen cross-linking, and IgE class switching requires IL-4.
Each pathologic process fundamentally depends on a specific immunologic pathway. Granulomatous diseases like tuberculosis rely on the Th1 response where IFN-gamma strongly activates macrophages. Psoriasis is a classic Th17-mediated disease driven by the synergistic effects of IL-17 and IL-23. Allergic asthma eosinophilia is specifically mediated by the Th2 cytokine IL-5. IgE class switching is distinctly driven by IL-4 signaling on B cells. Finally, toxic shock syndrome bypasses normal antigen processing via superantigens that broadly cross-link MHC-II and TCRs, resulting in a cytokine storm.

Step-by-Step Solution

1
Analyze the cellular infiltrate or primary pathologic feature of the described condition (e.g., granulomas require macrophage activation, allergic asthma requires eosinophils).
Identify the effector cells involved in each process.
Linking the condition to its effector cell narrows down the specific T-helper subset and corresponding cytokine.
2
Map the effector cell to its primary driving cytokine.
Macrophages map to IFN-gamma; Eosinophils map to IL-5; Neutrophils and Keratinocytes map to IL-17 and IL-23; IgE-producing B-cells map to IL-4.
Foundational immunology requires knowing the specific cytokines that activate these distinct downstream immunologic pathways.
3
Recognize the unique mechanism of massive, uncoordinated immune activation seen in toxic shock.
Identify superantigen cross-linking as the cause of the distributive shock.
This distinguishes specific antigen recognition from broad, non-specific T-cell activation which releases overwhelming amounts of TNF-alpha and IL-2.

Key Concept

Distinct immunopathologic processes are driven by specific cytokine axes (e.g., Th1/IFN-gamma for granulomas, Th2/IL-4/IL-5 for allergy, Th17/IL-17 for psoriasis, and superantigens for toxic shock), forming the foundational rationale for targeted biologic therapies.
Rate this question

Topics

Immunologic and Inflammatory Processes

More questions from this topic